Bioharvest Sciences (BHST) Gross Profit (2023 - 2025)

Bioharvest Sciences' Gross Profit history runs 3 years deep, the most recent figure standing at $5.2 million for Q4 2025.

• On a quarterly basis, Gross Profit rose 26.73% year-over-year to $5.2 million in Q4 2025; TTM through Dec 2025 was $20.5 million, a 46.87% increase from a year earlier, with the FY2025 full-year figure at $20.5 million, up 46.87% from the prior year.
• Gross Profit eased to $5.2 million in Q4 2025 per BHST's latest filing, from $5.6 million in the prior quarter.
• Across five years, Gross Profit topped out at $5.6 million in Q3 2025 and bottomed at $1.1 million in Q2 2023.
• The 3-year median for Gross Profit is $3.7 million (2024), against an average of $3.6 million.
• Across the five-year window, Gross Profit soared 180.47% in 2024 and gained 26.73% in 2025, its largest moves.
• Year by year, Gross Profit stood at $2.3 million in 2023, then soared by 79.81% to $4.1 million in 2024, then gained by 26.73% to $5.2 million in 2025.
• Per Business Quant, the three latest BHST Gross Profit figures stand at $5.2 million (Q4 2025), $5.6 million (Q3 2025), and $5.1 million (Q2 2025).